Leucas aspera: A computational approach to manage co-occurring Autoimmune diseases
Abstract
Autoimmune diseases such as Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Psoriasis (PS), Multiple Sclerosis (MS), and Sjogren's Syndrome (SS) occur when the immune system inflicts damage to the body in response to a trigger. Although each disease affects different areas of the human anatomy, they share common communities in their inflammatory and immunological pathways, with the involvement of proteins such as mitogen-activated protein kinase 1 (MAPK1), RAC-alpha serine/threonine-protein kinase (AKT1), and epidermal growth factor receptor (EGFR). The current use of anti-inflammatory and immunomodulatory treatments is associated with significant side effects. Thus, the growing interest in traditional medicine and ethnobiology has directed our attention to Leucas aspera, which is utilized in Ayurvedic and Chinese medicinal formulations for treating arthritis and psoriasis, suggesting the presence of bioactive phytochemicals capable of targeting critical pathways to mitigate their effects. This study conducted an in-depth analysis of bioactive phytocompounds from Leucas aspera and performed molecular docking, testing 71 plant-derived compounds against over 350 autoimmune-related gene targets found in selective autoimmune diseases. The most promising compounds were filtered and further examined for their interactions with major hub targets from network analysis by performing molecular dynamics simulations, underscoring their potential as attractive candidates. This study’s results provide a novel perspective on Leucas aspera in improving treatment protocols for various autoimmune diseases, minimizing adverse effects while increasing efficacy.
Keywords
Supporting Institution
Thanks
References
- Ahsan, H. (2017). Selfie: Autoimmunity, boon or bane. Journal of Immunoassay and Immunochemistry, 38(3), 235–246. https://doi.org/10.1080/15321819.2017.1319861
- Balkrishna, A., Sakat, S.S., Joshi, K., Paudel, S., Joshi, D., Joshi, K., Ranjan, R., Gupta, A., Bhattacharya, K., & Varshney, A. (2019). Herbo-mineral formulation “Ashwashila” attenuates rheumatoid arthritis symptoms in collagen-antibody-induced arthritis (CAIA) mice model. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-44485-9
- Baruah, V.J., Paul, R., Gogoi, D., Mazumder, N., Chakraborty, S., Das, A., Mondal, T.K., & Sarmah, B. (2022). Integrated computational approach toward discovery of multi-targeted natural products from Thumbai (Leucas aspera) for attuning NKT cells. Journal of Biomolecular Structure and Dynamics, 40(7), 2893–2907. https://doi.org/10.1080/07391102.2020.1844056
- Berman, H.M. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
- Bobkova, T., Bobkov, A., & Li, Y. (2025). Pharmacological Inhibition of the PI3K/AKT/mTOR Pathway in Rheumatoid Arthritis Synoviocytes: A Systematic Review and Meta-Analysis (Preclinical). Pharmaceuticals, 18(8), 1152–1152. https://doi.org/10.3390/ph18081152
- Burranboina, K.K., Kumar, K.M., Manjunatha Reddy, G.B., Yogisharadhya, R., Prashantha, C.N., & Dhulappa, A. (2022). GC-MS analysis, molecular Docking and pharmacokinetic studies of various bioactive compounds from methanolic leaf extracts of Leucas aspera (L) against anti - Capripox viral activity. Chemical Data Collections, 39, 100873. https://doi.org/10.1016/j.cdc.2022.100873
- Chaachouay, N., & Zidane, L. (2024). Plant-Derived Natural Products: A Source for Drug Discovery and Development. Drugs and Drug Candidates, 3(1), 184–207. https://doi.org/10.3390/ddc3010011
- Cushing, T.D., Metz, D.P., Whittington, D.A., & McGee, L.R. (2012). PI3Kδ and PI3Kγ as Targets for Autoimmune and Inflammatory Diseases. Journal of Medicinal Chemistry, 55(20), 8559–8581. https://doi.org/10.1021/jm300847w
Details
Primary Language
English
Subjects
Plant Biochemistry
Journal Section
Research Article
Authors
Anagha Chandan
This is me
0009-0006-7765-8865
India
Ananya Gb
This is me
0009-0009-3972-8369
India
Shravan R Shankar
This is me
0009-0009-0941-4553
India
Early Pub Date
May 3, 2026
Publication Date
June 9, 2026
Submission Date
June 11, 2025
Acceptance Date
February 15, 2026
Published in Issue
Year 2026 Volume: 13 Number: 2